Skip to content

Psychedelic-assisted therapy: all studies

Page 212 of 294: studies 2,111 to 2,120 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Neuropsychopharmacology December 1, 2023 Isabelle Straumann, Laura Ley, Friederike Holze et al. 41 citations

There is renewed interest in the use of lysergic acid diethylamide (LSD) in psychiatric research and practice. Although acute subjective effects of LSD are mostly positive, negative subjective effects, including anxiety, may occur. The induction of overall positive acute subjective effects is desired in psychedelic-assisted therapy because positive acute experiences are associated with greater...

Preclinical models of treatment-resistant depression: challenges and perspectives.

Pharmacological Reports December 1, 2023 Magdalena Kolasa, Agata Faron-Górecka 18 citations

Treatment-resistant depression (TRD) is a subgroup of major depressive disorder in which the use of classical antidepressant treatments fails to achieve satisfactory treatment results. Although there are various definitions and grading models for TRD, common criteria for assessing TRD have still not been established. However, a common feature of any TRD model is the lack of response to at least...

Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.

Drug Discovery Today December 1, 2023 Taeho Greg Rhee, Pasha A. Davoudian, Gerard Sanacora et al. 20 citations

Psychiatric disorders represent the largest cause of disability worldwide. Global interests in psychedelic substances as potentially therapeutic agents for psychiatric disorders has recently re-emerged. Here, we review progress in the development of psychedelic compounds that have potential therapeutic effects as well as the safety concerns. We include psilocybin, N,N-dimethyltryptamine (DMT),...

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic Medicine December 1, 2023 William Brennan, Alex R. Kelman, Alexander Belser 43 citations

Psychedelic-assisted therapy has gained significant attention in recent years. However, there is a lack of empirical clarity on the role of psychosocial interventions (PIs) in clinical trials of psychedelic treatment due in part to deficiencies in reporting practices found in the existing literature. These PI include non-drug support or interventions provided by psychotherapists or facilitators...

DOI: 10.1089/psymed.2023.0007 (opens in new tab) Full text (opens in new tab) Clinical trials Psychedelic-assisted therapy pat Psychosocial interventions Reporting practices +7

Call for evidence-based psychedelic integration.

Experimental and Clinical Psychopharmacology November 27, 2023 Jakub Greń, Ingmar Gorman, Anastasia Ruban et al. 27 citations

The use of psychedelics for various purposes was common in different civilizations throughout human history and has been explored scientifically for more than a century. Although the applications of psychedelics show promise in the treatment of various psychiatric and neurological indications, as well as in facilitation of well-being and personal growth, several psychedelic-related risks and...

Other Kinds of Mind There

Dancecult November 23, 2023 Trace Reddell

Cognition in extended brain-body music systems becomes especially agile during psychedelic experience, necessitating a sonic rhetoric emphasizing transformative agency. Rooted in the recursive listening spaces of dub, three forms of psychedelic electronica—ambient house, trip-hop and glitch—foster an echological sensibility unique to records made largely from the bits and pieces of other...

DOI: 10.12801/1947-5403.2023.15.01.02 (opens in new tab) Emotive Transformative learning Conversation Liminality +7

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Frontiers in Psychiatry November 23, 2023 Anya Ragnhildstveit, Ryan Khan, Paul Seli et al. 17 citations

Psychedelic therapy is, arguably, the next frontier in psychiatry. It offers a radical alternative to longstanding, mainstays of treatment, while exciting a paradigm shift in translational science and drug discovery. There is particular interest in 5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT)—a serotonergic psychedelic—as a novel, fast-acting therapeutic. Yet, few studies have directly...

DOI: 10.3389/fpsyt.2023.1271152 (opens in new tab) Adverse effect Psychopathology Clinical psychology

Milan Hausner, the Sadská Clinic, and The Fate of LSD Psychotherapy in Communist Czechoslovakia

The MIT Press eBooks November 21, 2023 Ross Crockford 1 citation

Hausner originally doubted that she could be helped.But as he listened to a recording of Hana's third LSD session, he saw some hope."The most pronounced aspect of this session is her archetypal regression into the realm of antiquity and to the very beginnings of humanity," Hausner later wrote. 1 "Hana is beginning to formulate a new attitude toward death and eternity."Over the next six months,...

From Psychiatric Clinics to Magical Center: LSD in the Netherlands

The MIT Press eBooks November 21, 2023 Stephen Snelders 1 citation

Dutch psychedelic history had its own characteristics. In psychiatry, LSD therapy was used for the management of the traumas of World War II; in Dutch society, overlapping groups of activists and psychedelics users were involved in a playful transformation of society into a “Magical Center”; and in economics, the Netherlands became a key player in the illegal production and distribution of LSD...

DOI: 10.7551/mitpress/14417.003.0023 (opens in new tab) Full text (opens in new tab) Center category theory Magical thinking Alternative medicine

Psychedelics in Israel: A Brief History

The MIT Press eBooks November 21, 2023 Ido Hartogsohn, Itamar Zadoff 2 citations

As of 2021, Israel is positioned at the forefront of a global revival of psychedelic research and culture.The small Middle Eastern country hosts clinical trials with psychedelics, generates multiple psychedelic start-ups, and hosts a pioneering psychedelic therapy training program.Popu lar interest in psychedelics is surging throughout the country as well, with multiple conferences, podcasts,...